Literature DB >> 21172551

Tissue-engineered cardiac constructs for cardiac repair.

Shigeru Miyagawa1, Matthias Roth, Atsuhiro Saito, Yoshiki Sawa, Sawa Kostin.   

Abstract

Several recent basic research studies have described surgical methods for cardiac repair using tissue cardiomyoplasty. This review summarizes recent advances in cardiac repair using bioengineered tissue from the viewpoint of the cardiac surgeon. We conclude that the results of many basic and preclinical studies indicate that bioengineered tissue can be adapted to conventional surgical techniques. However, no clinical studies have yet proved bioengineered tissue is effective as a treatment for human heart failure. Today's cardiac surgeons can look forward to the advent of new techniques to benefit patients who respond poorly to existing treatment for heart failure.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21172551     DOI: 10.1016/j.athoracsur.2010.09.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  26 in total

1.  Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.

Authors:  Masashi Kawamura; Shigeru Miyagawa; Satsuki Fukushima; Atsuhiro Saito; Koichi Toda; Takashi Daimon; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Tissue Eng Part A       Date:  2015-07-14       Impact factor: 3.845

Review 2.  Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration.

Authors:  Nicholas J Kaiser; Kareen L K Coulombe
Journal:  Biomed Mater       Date:  2015-05-13       Impact factor: 3.715

Review 3.  Heart repair and regeneration: recent insights from zebrafish studies.

Authors:  Ching-Ling Lien; Michael R Harrison; Tai-Lan Tuan; Vaughn A Starnes
Journal:  Wound Repair Regen       Date:  2012-07-20       Impact factor: 3.617

Review 4.  Regenerating functional heart tissue for myocardial repair.

Authors:  Andre Alcon; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

5.  Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro.

Authors:  C Williams; K P Quinn; I Georgakoudi; L D Black
Journal:  Acta Biomater       Date:  2013-09-06       Impact factor: 8.947

6.  Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.

Authors:  Yasushi Yoshikawa; Shigeru Miyagawa; Koichi Toda; Atsuhiro Saito; Yasushi Sakata; Yoshiki Sawa
Journal:  Surg Today       Date:  2017-08-18       Impact factor: 2.549

7.  Bioengineering the infarcted heart by applying bio-inspired materials.

Authors:  Emil Ruvinov; Tamar Harel-Adar; Smadar Cohen
Journal:  J Cardiovasc Transl Res       Date:  2011-06-08       Impact factor: 4.132

8.  Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue.

Authors:  Nasim Annabi; Kelly Tsang; Suzanne M Mithieux; Mehdi Nikkhah; Afshin Ameri; Ali Khademhosseini; Anthony S Weiss
Journal:  Adv Funct Mater       Date:  2013-10-18       Impact factor: 18.808

9.  A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy.

Authors:  Yasuhiro Shudo; Jeffrey E Cohen; John W MacArthur; Andrew B Goldstone; Satoru Otsuru; Alen Trubelja; Jay Patel; Bryan B Edwards; George Hung; Alexander S Fairman; Christopher Brusalis; William Hiesinger; Pavan Atluri; Arudo Hiraoka; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo
Journal:  Tissue Eng Part A       Date:  2015-09-18       Impact factor: 3.845

Review 10.  Myocardial regeneration of the failing heart.

Authors:  Alexander T Akhmedov; José Marín-García
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.